Bolt Biotherapeutics, Inc. (BOLT) vs Enveric Biosciences, Inc. (ENVB)
A side-by-side comparison of Bolt Biotherapeutics, Inc. and Enveric Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BOLT
Bolt Biotherapeutics, Inc.
$3.64HealthcareDelayed quote: Oct 6, 2026, 11:51 AM EDT
ENVB
Enveric Biosciences, Inc.
$1.47HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT
Total return — BOLT vs ENVB
growth of $100 · dividends reinvested · last 5yBOLT -99.3% (-62.6%/yr)ENVB -100.0% (-82.5%/yr)BOLT compounded faster over this window
Log scale — wide-divergence pair
BOLT ENVB
BOLT vs ENVB: by the numbers
- •BOLT is the larger company ($7M vs $7M market cap).
- •Both run net losses; ENVB's is the smaller (0.00% vs -611.47% net margin).
Metrics side by side
Valuation
| Metric | BOLT | ENVB |
|---|---|---|
| P/S ratio | 1.49 | N/A |
| P/B ratio | 0.55 | 0.81 |
Profitability
| Metric | BOLT | ENVB |
|---|---|---|
| Gross margin | 80.62% | 0.00% |
| Operating margin | -450.07% | 0.00% |
| Net margin | -611.47% | 0.00% |
| ROE | -227.37% | -108.00% |
| ROIC | -90.17% | -107.99% |
Growth (annualized)
| Metric | BOLT | ENVB |
|---|---|---|
| Total return CAGR (5Y) | -57.61% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.